Pharmacopsychiatry Covering all new advances in the field of psychotropic drugs, Pharmacopsychiatry provides psychiatrists, neuroscientists and clinicians with key clinical insights and describes new avenues of research and treatment. The pharmacological and neurobiological bases of psychiatric disorders are discussed by presenting clinical and experimental research. Pharmacopsychiatry publishes information about controlled clinical trials and meeting proceedings, and serves as a state-of-the-art tool for advancing the field and setting European standards. Includes sections on: Basic/translational/clinical psychopharmacology Biological psychiatry Neuroimaging and neurophysiology Basic and clinical neurosciences Biological psychology Pharmacogenetics
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Medicine (miscellaneous)Q1
Pharmacology (medical)Q2
Psychiatry and Mental HealthQ2
Subject Classification
Web of Science Categories
Pharmacology & PharmacyPsychiatry
Scopus Categories
Pharmacology (medical)Psychiatry and Mental HealthMedicine (miscellaneous)
Research Topics (OpenAlex)
Schizophrenia research and treatmentTreatment of Major DepressionBipolar Disorder and TreatmentElectroconvulsive Therapy StudiesNeurotransmitter Receptor Influence on BehaviorTryptophan and brain disordersStress Responses and CortisolAttention Deficit Hyperactivity DisorderNeuroscience and Neuropharmacology ResearchEpilepsy research and treatment